Evidence map›Paper›PMID 25010746›Full record

ArticlePloS one2014

A comparison of podocyturia, albuminuria and nephrinuria in predicting the development of preeclampsia: a prospective study.

Belinda Jim, Swati Mehta, Andi Qipo, Kwanghee Kim, Hillel W Cohen, Robert M Moore, John C He, Shuchita Sharma

Open access · goldAbstract readComparative Study
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 2 pooled it
3.9field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 2 syntheses or guidelines pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Urinary Nephrin Concentrations in Preeclampsia (with and without Complications) vs Normal Pregnancies.Medical science monitor : international medical journal of experimental and clinical research · 2025
    Observational
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Observational
  12. Observational
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Belinda JimJacobi Medical Center, Albert Einstein College of Medicine, Department of Nephrology/Medicine, Bronx, New York, United States of America.
Swati MehtaJames J. Peters VA Medical Center, Department of Nephrology/Medicine, Bronx, New York, United States of America.
Andi QipoJacobi Medical Center, Albert Einstein College of Medicine, Department of Nephrology/Medicine, Bronx, New York, United States of America.
Kwanghee KimProvidence Alaska Medical Center, Anchorage, Alaska, United States of America.
Hillel W CohenAlbert Einstein College of Medicine, Department of Epidemiology and Population Health, Bronx, New York, United States of America.
Robert M MooreJacobi Medical Center, Albert Einstein College of Medicine, Department of Obstetrics and Gynecology, Bronx, New York, United States of America.
John C HeJames J. Peters VA Medical Center, Department of Nephrology/Medicine, Bronx, New York, United States of America; Mount Sinai School of Medicine, Department of Nephrology/Medicine, New York, New York, United States of America.
Shuchita SharmaMount Sinai School of Medicine, Department of Nephrology/Medicine, New York, New York, United States of America.
Jacobi Medical Center · USIcahn School of Medicine at Mount Sinai · USAlbert Einstein College of Medicine · USJames J. Peters VA Medical Center · USProvidence Alaska Medical Center · US

Funding

Core-010UL1TR001073 · NCATS · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI KELLER, MARLA J, SHAMOON, HARRY · 2013 to 2017
$21.3M
Clinical and Translational Science AwardKL2TR001071 · NCATS · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI SHAMOON, HARRY · 2013 to 2017
$968k
Clinical and Translational Science AwardTL1TR001072 · NCATS · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI SHAMOON, HARRY · 2013 to 2017
$909k
NCATS NIH HHS 1 KL2 TR001071-01NCATS NIH HHS 1 TL1 TR001072-01NCATS NIH HHS 1 UL1 TR001073-01NCATS NIH HHS KL2 TR001071NCATS NIH HHS TL1 TR001072NCATS NIH HHS UL1 TR001073
6 · The paper itself

Abstract

Preeclampsia, a hypertensive multisystem disease that complicates 5-8% of all pregnancy, is a major cause for maternal and fetal mortality and morbidity. The disease is associated with increased spontaneous and evoked preterm birth and remote cardio-renal disorders in the mother and offspring. Thus the ability to predict the disease should lead to earlier care and decreased morbidity. This has led to fervent attempts to identify early predictive biomarkers and research endeavors that have expanded as we learn more regarding possible causes of the disease. As preeclampsia is associated with specific renal pathology including podocyte injury, early urinary podocyte (podocyturia), or the podocyte specific proteinuria nephrin in the urine (nephrinuria), as well as the more easily measured urinary albumin (albuminuria), have all been suggested as predictive markers. We performed a prospective study recruiting 91 pregnant women (78 of whom were high risk) and studied the predictive ability of these three urinary biomarkers. The subjects were recruited between 15-38 weeks of gestation. Fourteen patients, all in the high-risk obstetric group, developed preeclampsia. The levels of podocyturia, nephrinuria, and albuminuria were variably higher in the high-risk pregnant patients who developed preeclampsia. The sensitivities and specificities for podocyturia were 70% and 43%, for albuminuria were 36% and 96%, and for nephrinuria were 57% and 58%, respectively. Also, abnormal nephrinuria (69%) and podocyturia (38%) were detected in low risk women who had uncomplicated gestations; none of these women exhibited albuminuria. In our study, none of the three urinary markers achieved the minimum predictive values required for clinical testing. The lack of excessive albuminuria, however, may indicate a preeclampsia-free gestation. Given a discrepant literature, further studies with larger sample size should be considered.

Indexed as

AdultAlbuminuriaBiomarkersCreatinineFemaleHumansMembrane ProteinsPodocytesPre-EclampsiaPregnancyPregnancy Trimester, SecondPregnancy Trimester, ThirdProspective StudiesRiskBiomarkersCreatinineMembrane Proteinsnephrin

Identifiers

PMID25010746
PMCPMC4092019
OpenAlexW2050556547

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.